237 related articles for article (PubMed ID: 8777988)
1. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.
Koopmans SJ; Sips HC; Krans HM; Radder JK
Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988
[TBL] [Abstract][Full Text] [Related]
2. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
[TBL] [Abstract][Full Text] [Related]
3. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
Yu ZW; Jansson PA; Posner BI; Smith U; Eriksson JW
Diabetologia; 1997 Oct; 40(10):1197-203. PubMed ID: 9349602
[TBL] [Abstract][Full Text] [Related]
4. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
Wu H; Sui C; Xu H; Xia F; Zhai H; Zhang H; Weng P; Han B; Du S; Lu Y
J Diabetes Res; 2014; 2014():524517. PubMed ID: 25580440
[TBL] [Abstract][Full Text] [Related]
5. Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations.
Koopmans SJ; Sips HC; Bosman J; Radder JK; Krans HM
Endocrinology; 1989 Dec; 125(6):3044-50. PubMed ID: 2684615
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.
Rossetti L; DeFronzo RA; Gherzi R; Stein P; Andraghetti G; Falzetti G; Shulman GI; Klein-Robbenhaar E; Cordera R
Metabolism; 1990 Apr; 39(4):425-35. PubMed ID: 2157941
[TBL] [Abstract][Full Text] [Related]
7. Lowering of plasma glucose in diabetic rats by antilipolytic agents.
Reaven GM; Chang H; Ho H; Jeng CY; Hoffman BB
Am J Physiol; 1988 Jan; 254(1 Pt 1):E23-30. PubMed ID: 2962514
[TBL] [Abstract][Full Text] [Related]
8. Whole body and hepatic insulin action in normal, starved, and diabetic rats.
Koopmans SJ; de Boer SF; Sips HC; Radder JK; Frölich M; Krans HM
Am J Physiol; 1991 Jun; 260(6 Pt 1):E825-32. PubMed ID: 2058659
[TBL] [Abstract][Full Text] [Related]
9. The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
Gao L; Niu Y; Liu W; Xie M; Liu X; Chen Z; Li L
Clin Chim Acta; 2008 Feb; 388(1-2):89-94. PubMed ID: 17991430
[TBL] [Abstract][Full Text] [Related]
10. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man.
Courtney CH; Atkinson AB; Ennis CN; Sheridan B; Bell PM
Metabolism; 2003 Aug; 52(8):1050-5. PubMed ID: 12898472
[TBL] [Abstract][Full Text] [Related]
12. Basal lipolysis in epididymal fat cells from streptozotocin-induced diabetic rats.
Tsujita T
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):47-53. PubMed ID: 16637229
[TBL] [Abstract][Full Text] [Related]
13. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
[TBL] [Abstract][Full Text] [Related]
14. d-Fenfluramine improves hepatic insulin action in streptozotocin-diabetic rats.
Picarel-Blanchot F; Bailbé D; Portha B
Eur J Pharmacol; 1994 Oct; 264(2):227-32. PubMed ID: 7851488
[TBL] [Abstract][Full Text] [Related]
15. Normal insulin sensitivity during the phase of glucose intolerance but insulin resistance at the onset of diabetes in the spontaneously diabetic BB rat.
Baudon MA; Ferré P; Pénicaud L; Maulard P; Ktorza A; Castano L; Girard J
Diabetologia; 1989 Dec; 32(12):839-44. PubMed ID: 2693164
[TBL] [Abstract][Full Text] [Related]
16. Effects of glimepiride on in vivo insulin action in normal and diabetic rats.
Sato J; Ohsawa I; Oshida Y; Sato Y; Sakamoto N
Diabetes Res Clin Pract; 1993; 22(1):3-9. PubMed ID: 8137714
[TBL] [Abstract][Full Text] [Related]
17. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
[TBL] [Abstract][Full Text] [Related]
18. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
[TBL] [Abstract][Full Text] [Related]
19. In vivo insulin responsiveness for glucose uptake and production at eu- and hyperglycemic levels in normal and diabetic rats.
Koopmans SJ; Maassen JA; Radder JK; Frölich M; Krans HM
Biochim Biophys Acta; 1992 Jan; 1115(3):230-8. PubMed ID: 1739737
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes.
Szkudelska K; Nogowski L; Szkudelski T
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):17-24. PubMed ID: 19041941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
